Validations: Biologics, ATMP & Viral Safety Validation
Complex CQAs in Biologics/ATMP: Potency, Identity, and Purity Complex CQAs in Biologics/ATMP: Potency, Identity, and Purity In the realm of pharmaceuticals, particularly with Biologics and Advanced Therapy Medicinal Products (ATMPs), the critical quality attributes (CQAs) surrounding potency, identity, and purity have become increasingly complex. Regulatory guidelines such as ICH Q5A(R2), FDA process validation requirements, and the new aseptic controls outlined…
Potency Assays: Cell-Based vs Binding—Which and Why In the realm of biotechnology and pharmaceuticals, potency assays play a crucial role in ensuring the efficacy and safety of biologics and advanced therapy medicinal products (ATMPs). As regulatory agencies such as the FDA, EMA, and MHRA increasingly scrutinize these methods, understanding the distinctions between cell-based assays and binding assays is fundamental for…
Potency Assays: Cell-Based vs Binding—Which and Why Introduction to Potency Assays in Biologics Validation In the realm of biopharmaceutical development and manufacturing, the validation of potency assays is a critical component, particularly when engaging with advanced therapeutic medicinal products (ATMPs) and biologics. Potency assays serve as key quality control mechanisms to assess a product’s therapeutic efficacy and ensure consistent performance…
Identity Testing: Sequencing, Proteomics, and Flow Cytometry Identity Testing: Sequencing, Proteomics, and Flow Cytometry Introduction to Identity Testing in Biologics Identity testing is a fundamental aspect of the validation process for biologics and advanced therapy medicinal products (ATMP). It encompasses various methodologies and technologies including sequencing, proteomics, and flow cytometry. The validation of identity is critical as it assures product…
Aseptic Interventions: Minimization and Justification Aseptic Interventions: Minimization and Justification Understanding Aseptic Processes in Biologics and ATMPs Aseptic processing is a critical component in the manufacturing of biologics and advanced therapy medicinal products (ATMPs). The goal of aseptic interventions is to minimize the risk of contamination during production and ensure product safety and efficacy. To meet regulatory expectations, organizations must…
Aseptic Interventions: Minimization and Justification Aseptic Interventions: Minimization and Justification Aseptic processing is a central element in the production of biologics and advanced therapy medicinal products (ATMPs). It relies heavily on stringent aseptic controls to ensure product safety and efficacy. This article serves as a comprehensive guide that details the principles, processes, and regulatory considerations associated with minimizing and justifying…
Annex 1 Visual Inspection Links for ATMP Advanced therapy medicinal products (ATMPs) are a revolutionary class of medicines that require meticulous validation processes to ensure their safety, efficacy, and quality. A key component in the quality assurance of ATMPs is the validation of aseptic controls outlined in regulatory standards such as Annex 1 of the EU GMP guidelines. This article…
Annex 1 Visual Inspection Links for ATMP Aseptic manufacturing processes for Advanced Therapy Medicinal Products (ATMPs) require stringent controls and validation to ensure product quality and patient safety. As defined by regulatory guidance from entities such as the US FDA, EMA, and MHRA, the importance of robust aseptic controls cannot be overstated. This guide serves as a comprehensive tutorial on…
Closed System Deviations: Investigation & CAPA Closed System Deviations: Investigation & CAPA In the realm of biologics and advanced therapy medicinal products (ATMP), stringent validation protocols are essential for ensuring safety and efficacy. This article details a comprehensive approach to investigating closed system deviations, addressing corrective and preventive actions (CAPA) underpinned by regulatory standards such as those set forth by…
Closed System Deviations: Investigation & CAPA Closed System Deviations: Investigation & CAPA Understanding Closed Systems and Their Importance in Aseptic Controls Closed systems represent a vital aspect of aseptic processing within pharmaceutical manufacturing, especially for biologics and advanced therapy medicinal products (ATMP). In these environments, maintaining sterility while handling sensitive products is paramount to ensuring safety and efficacy. The aseptic…